Estimation of time parameter of LQ-model in fractionated radiotherapy of medulloblastoma

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 19, Issue 2, 2001, Pages 61-70

  Hinata, H ^a   Inakoshi, H ^a   Sakai, K ^a   Ogawa, Y ^a   Kobayashi, M ^a   Wakushima, H ^a   Obara, T ^a   Shibamoto, Y ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Accelerated proliferation; Dose time factor; Local control; Medulloblastoma; Radiotherapy

Indexed keywords

ARTICLE; ASSAY; CALCULATION; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; MEDULLOBLASTOMA; MODEL; RADIATION DOSE FRACTIONATION; SCORING SYSTEM; TUMOR CELL;

CEREBELLAR NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TIME FACTORS;

EID: 0034987813     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx
2. Further analysis of the time factor in squamous cell carcinoma of the tonsillar region
3. Esophageal cancer treated with radiotherapy: Impact of total treatment time and fractionation
4. Local control of operable breast cancer after radiotherapy alone
5. The influence of the number of fractions, overall treatment time and field size on the local control of cancer of the skin
6. Medulloblastoma: Time-dose relationship based on a 30-year review
7. The kinetics of tumour cell proliferation and radiotherapy
8. Repopulation in human tumors: A biological background for fractionation in radiotherapy
9. The hazard of accelerated tumor clonogen repopulation during radiotherapy
10. Loss of local control with prolongation in radiotherapy
11. Direct analysis of quantal response data
12. Analysis of factors influencing local control of medulloblastoma
13. Tumor cell proliferation and apoptosis in medulloblastoma
14. Cell kinetics of medulloblastoma
15. The linear-quadratic formula and progress in fractionated radiotherapy
16. The delay before onset of accelerated tumour cell repopulation during radiotherapy: A direct maximum-likelihood analysis of a collection of worldwide tumour-control data
17. Dose fractionation, dose rate and isoeffect relationships for normal tissue responses
18. Isoeffet models and fractionated radiation therapy
19. New options in direct analysis of dose-response data
20. Regression models and life tables
21. Characterization and radiobiologic parameters of medulloblastoma in vitro
22. A review of α/β ratios for experimental tumors: Implications for clinical studies of altered fractionation
23. In vitro radiosensitivity of human medulloblastoma cell lines
24. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy
25. Fractionation parameters for human tissues and tumors
26. Tumour cell repopulation in the rest interval of split-course radiation treatment
27. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx
28. Deriving absolute value of α and β for dose fractionation, using dose-incidence data
29. Treatment acceleration in radiotherapy: The relative time factors and dose-response slopes for tumours and normal tissues
30. Clinical evidence for clonogen regeneration: Interpretations of the data
31. Local control, TCD50 and dose-time prescription habits in radiotherapy of head and neck tumours
32. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation
33. Dose-time considerations of head and neck squamous cell carcinoma treated with irradiation
34. Clinical radiobiology of squamous cell carcinoma of the oropharynx
35. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer
36. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy
37. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer
38. The influence of radiotherapy treatment time on the control of laryngeal cancer: A direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor
39. Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions
40. Effect of overall treatment time on local control in radical radiotherapy for squamous cell carcinoma of esophagus
41. Letter to the editor
42. Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy
43. Medulloblastoma at the Joint Center for Radiation Therapy between 1968 and 1984: The influence of radiation dose on the patterns of failure and survival
44. Posterior fossa medulloblastoma in childhood: Treatment results and a proposal for a new staging system
45. Influence of radiotherapy treatment time on control of laryngeal cancer: Comparisons between centres in Manchester, UK and Toronto, Canada
46. Non-linear effects in dose-time analyses: Application of modern statistical techniques